PL355998A1 - Kompozycje zawierające pochodne kwasu hydroksyeikozatetraenowego oraz sposoby ich zastosowania w leczeniu zespołu suchego oka - Google Patents

Kompozycje zawierające pochodne kwasu hydroksyeikozatetraenowego oraz sposoby ich zastosowania w leczeniu zespołu suchego oka

Info

Publication number
PL355998A1
PL355998A1 PL00355998A PL35599800A PL355998A1 PL 355998 A1 PL355998 A1 PL 355998A1 PL 00355998 A PL00355998 A PL 00355998A PL 35599800 A PL35599800 A PL 35599800A PL 355998 A1 PL355998 A1 PL 355998A1
Authority
PL
Poland
Prior art keywords
methods
compositions containing
acid derivatives
dry eye
eye disorders
Prior art date
Application number
PL00355998A
Other languages
English (en)
Inventor
L.Wayne Schneider
Daniel A. Gamache
Lori K. Weimer
Timothy L. Kessler
Zhongyou Wei
Terri Pasquine
John M. Yanni
Haresh G. Bhagat
Original Assignee
Alcon Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc. filed Critical Alcon Inc.
Publication of PL355998A1 publication Critical patent/PL355998A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL00355998A 1999-11-09 2000-10-23 Kompozycje zawierające pochodne kwasu hydroksyeikozatetraenowego oraz sposoby ich zastosowania w leczeniu zespołu suchego oka PL355998A1 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US16437099P 1999-11-09 1999-11-09
US16438599P 1999-11-09 1999-11-09
US16438499P 1999-11-09 1999-11-09
PCT/US2000/029225 WO2001034554A1 (en) 1999-11-09 2000-10-23 Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders

Publications (1)

Publication Number Publication Date
PL355998A1 true PL355998A1 (pl) 2004-05-31

Family

ID=27389013

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00355998A PL355998A1 (pl) 1999-11-09 2000-10-23 Kompozycje zawierające pochodne kwasu hydroksyeikozatetraenowego oraz sposoby ich zastosowania w leczeniu zespołu suchego oka

Country Status (20)

Country Link
US (1) US6353022B1 (pl)
EP (1) EP1228032B1 (pl)
JP (1) JP2003513951A (pl)
KR (1) KR20020050239A (pl)
CN (1) CN1387505A (pl)
AR (1) AR029190A1 (pl)
AT (1) ATE272603T1 (pl)
AU (1) AU775189B2 (pl)
BR (1) BR0015416A (pl)
CA (1) CA2386619A1 (pl)
DE (1) DE60012774T2 (pl)
DK (1) DK1228032T3 (pl)
ES (1) ES2220561T3 (pl)
HK (1) HK1045986B (pl)
MX (1) MXPA02004703A (pl)
PL (1) PL355998A1 (pl)
PT (1) PT1228032E (pl)
TR (1) TR200201246T2 (pl)
TW (1) TWI267375B (pl)
WO (1) WO2001034554A1 (pl)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USH1511H (en) * 1992-09-10 1995-12-05 Chappell; Charles W. Absorbent articles having improved longitudinal fluid movement
US6919076B1 (en) 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
US6958148B1 (en) 1998-01-20 2005-10-25 Pericor Science, Inc. Linkage of agents to body tissue using microparticles and transglutaminase
US20020077358A1 (en) * 2000-10-23 2002-06-20 Alcon Universal Ltd. Use of hydroperoxyeicosatetraenoic acid derivatives following refractive surgery
WO2002034258A1 (en) * 2000-10-23 2002-05-02 Alcon, Inc. Use of hydroxyeicosatetraenoic acid derivatives in intraocular surgery
US20020183233A1 (en) * 2000-12-14 2002-12-05 The Clorox Company, Delaware Corporation Bactericidal cleaning wipe
US7799751B2 (en) * 2000-12-14 2010-09-21 The Clorox Company Cleaning composition
US20030100465A1 (en) * 2000-12-14 2003-05-29 The Clorox Company, A Delaware Corporation Cleaning composition
US20030109508A1 (en) * 2001-10-11 2003-06-12 Alcon, Inc. Methods for treating dry eye
FR2833268B1 (fr) * 2001-12-12 2005-07-08 Fabre Pierre Dermo Cosmetique Nouvelle association contenant un poloxamer et de l'acide chondroitine sulfurique et/ou une glycoproteine et son utilisation
JP4836401B2 (ja) * 2002-04-01 2011-12-14 ロート製薬株式会社 眼科用組成物
JP2005289814A (ja) * 2002-04-12 2005-10-20 Mei Co Ltd 近視矯正手術のための医薬
AU2003221707A1 (en) * 2002-06-14 2003-12-31 Alcon, Inc. Topical use of hydroxyeicosatetraenoic acid compounds to treat psoriasis
US6825232B2 (en) * 2002-06-14 2004-11-30 Alcon, Inc. Use of hydroxyeicosatetraenoic acid compounds to treat ophthalmic inflammatory disorders
FR2843026B1 (fr) * 2002-08-02 2006-01-06 Goemar Lab Sa Nouveau medicament
AU2003278727A1 (en) * 2002-09-20 2004-04-08 Alcon, Inc. Use of cytokine synthesis inhibitors for the treatment of dry eye disorders
GB0411165D0 (en) * 2004-05-19 2004-06-23 Bionovate Ltd Hyaluronic acid containing pharmaceutical or veterinary compounds
TWI393567B (zh) * 2005-03-31 2013-04-21 Bausch & Lomb 治療乾眼之組合物及相關之製造方法及使用方法
US20210121430A1 (en) 2011-07-18 2021-04-29 Prn Physician Recommended Nutriceuticals, Llc Omega-3 fatty acid supplementation for use in treating dry eye
US9381183B2 (en) 2012-07-18 2016-07-05 Physicians Recommended Nutriceuticals, Llc Methods for improving the quality of the meibum composition of meibomian glands
US9115078B2 (en) 2011-07-18 2015-08-25 Physicians Recommended Nutriceuticals, Llc Compositions for improving the quality of the meibum composition of inflamed or dysfunctional meibomian glands
US10709680B2 (en) 2011-07-18 2020-07-14 Physicians Recommended Nutriceuticals, Llc Methods for treating dry eye
CN104661682B (zh) * 2012-09-27 2018-05-11 千寿制药株式会社 水性液剂
US9320709B2 (en) * 2013-08-28 2016-04-26 Presbyopia Therapies Llc Storage stable compositions and methods for the treatment of refractive errors of the eye
WO2016205068A1 (en) * 2015-06-18 2016-12-22 Presbyopia Therapies, LLC Storage stable compositions and methods for the treatment of refractive errors of the eye
US20210251970A1 (en) 2018-10-10 2021-08-19 Presbyopia Therapies Inc Compositions and methods for storage stable ophthalmic drugs
US12180206B2 (en) 2021-11-17 2024-12-31 Lenz Therapeutics Operations, Inc. Aceclidine derivatives, compositions thereof and methods of use thereof
US11648247B1 (en) 2021-12-16 2023-05-16 Lenz Therapeutics, Inc. Compositions and methods for the treatment of presbyopia
US12414942B1 (en) 2024-03-15 2025-09-16 Lenz Therapeutics Operations, Inc. Compositions, methods, and systems for treating presbyopia

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991759A (en) 1975-10-28 1976-11-16 Alza Corporation Method and therapeutic system for treating aqueous deficient dry eye
US4131651A (en) 1977-10-25 1978-12-26 Barnes-Hind Pharmaceuticals, Inc. Treatment of dry eye
US4409205A (en) 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
US4370325A (en) 1979-03-30 1983-01-25 Dermik Laboratories Pharmaceutical compositions and method of treatment
AU546872B2 (en) 1982-06-16 1985-09-26 Unilever Plc Skin treatment compositions containing a fatty acid or ester
US4421748A (en) 1982-07-13 1983-12-20 Trager Seymour F Artificial tear aid
GB8319073D0 (en) 1983-07-14 1983-08-17 Efamol Ltd Fatty acid compositions
US4753945A (en) 1986-02-19 1988-06-28 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with phosphodiesterase inhibitors
US4868154A (en) 1986-02-19 1989-09-19 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with melanocyte stimulating hormones
US4744980A (en) 1986-04-28 1988-05-17 Holly Frank J Ophthalmic solution for treatment of dry eye syndrome
US4883658A (en) 1986-04-28 1989-11-28 Holly Frank J Ophthalmic solution for treatment of dry-eye syndrome
US4818537A (en) 1986-10-21 1989-04-04 Liposome Technology, Inc. Liposome composition for treating dry eye
US4966773A (en) 1986-11-25 1990-10-30 Alcon Laboratories, Inc. Topical ophthalmic compositions containing microfine retinoid particles
US4914088A (en) 1987-04-02 1990-04-03 Thomas Glonek Dry eye treatment solution and method
US5278151A (en) 1987-04-02 1994-01-11 Ocular Research Of Boston, Inc. Dry eye treatment solution
US4921644A (en) 1988-02-29 1990-05-01 Technology Unlimited, Inc. Mucin directed lipsome
US4906467A (en) 1988-03-24 1990-03-06 New York Medical College Novel, long-duration treatment for glaucoma
US4923700A (en) 1988-06-03 1990-05-08 Kaufman Herbert E Artificial tear suspension
US5064655A (en) 1989-02-24 1991-11-12 Liposome Technology, Inc. Liposome gel composition and method
US5075104A (en) 1989-03-31 1991-12-24 Alcon Laboratories, Inc. Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
US5174988A (en) 1989-07-27 1992-12-29 Scientific Development & Research, Inc. Phospholipid delivery system
WO1991012808A1 (en) 1990-02-22 1991-09-05 Macnaught Pty Limited Artificial tears
US5041434A (en) 1991-08-17 1991-08-20 Virginia Lubkin Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
DE69115990T2 (de) 1990-05-29 1996-05-30 Ocular Res Of Bonton Inc Zusammensetzung zur Behandlung von Dry Eye Erkrankungen
ZA912797B (en) 1990-05-29 1992-12-30 Boston Ocular Res Dry eye treatment process and solution
US5102670A (en) 1990-09-14 1992-04-07 Abraham Nader G Method for treating eye disorders by reducing 12(r)-hydroxyeicosatetraenoic acid and 12(r)-dihydroxyeicosatrienoic acid levels
DE69212850T2 (de) 1991-01-15 1997-03-06 Alcon Lab Inc Verwendung von Karrageenan in topischen ophthalmologischen Zusammensetzungen
ZA927277B (en) 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
EP0546728A3 (en) 1991-12-13 1993-09-08 Alcon Laboratories Inc Physiological tear compositions and methods for their preparation
CA2133966C (en) 1992-04-21 1997-09-09 David A. Sullivan Ocular androgen therapy in sjogren's syndrome
US5290572A (en) 1992-08-06 1994-03-01 Deo Corporation Opthalmic composition for treating dry eye
US5358706A (en) 1992-09-30 1994-10-25 Union Carbide Chemicals & Plastics Technology Corporation Muco-adhesive polymers
US5455265A (en) 1993-02-11 1995-10-03 Allergan, Inc. Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors
US5389383A (en) 1993-06-18 1995-02-14 Allergan, Inc. Method for treating hypoxia-associated ocular complications
US5696166A (en) 1995-10-31 1997-12-09 Yanni; John M. Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
US5676166A (en) * 1996-09-11 1997-10-14 Chang; Wen-Shyong Hair clip
US5800807A (en) 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol

Also Published As

Publication number Publication date
ATE272603T1 (de) 2004-08-15
AR029190A1 (es) 2003-06-18
MXPA02004703A (es) 2004-09-10
JP2003513951A (ja) 2003-04-15
TWI267375B (en) 2006-12-01
PT1228032E (pt) 2004-10-29
EP1228032B1 (en) 2004-08-04
US6353022B1 (en) 2002-03-05
CN1387505A (zh) 2002-12-25
CA2386619A1 (en) 2001-05-17
TR200201246T2 (tr) 2002-09-23
KR20020050239A (ko) 2002-06-26
AU775189B2 (en) 2004-07-22
WO2001034554A1 (en) 2001-05-17
DE60012774T2 (de) 2005-01-13
HK1045986A1 (en) 2002-12-20
ES2220561T3 (es) 2004-12-16
DK1228032T3 (da) 2004-11-01
DE60012774D1 (de) 2004-09-09
AU1340801A (en) 2001-06-06
BR0015416A (pt) 2002-07-16
HK1045986B (en) 2004-12-24
EP1228032A1 (en) 2002-08-07

Similar Documents

Publication Publication Date Title
PL355998A1 (pl) Kompozycje zawierające pochodne kwasu hydroksyeikozatetraenowego oraz sposoby ich zastosowania w leczeniu zespołu suchego oka
PL356093A1 (pl) Hydroksyeikozatetraeniany, sole, kompozycje i sposoby ich zastosowania w leczeniu zespołu suchego oka
PL344589A1 (en) COMPOSITION COMPRISING β-HYDROXY-β-METHYLBUTYRIC ACID AND AT LEAST ONE AMINO ACID AND METHODS OF USE
HUP0104867A3 (en) Heterocyclic compounds useful in the treatment of inflammatory diseases, process for their preparation, pharmaceutical compositions comprising thereof and their use
IL147217A0 (en) New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain
EP1229930A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALLERGIC DISORDERS
IL127943A0 (en) Pharmaceutical and cosmetic composition for the treatment of skin disorders
PL331006A1 (en) Risk assessing method for use in cardiovascular diseases and other diseases as well as phytosterol-based compositions useful in prophylaxis and treatment of cardiovascular and other diseases
AU4340700A (en) Methods and compositions for use in the treatment of hyperlipidemia
PL349193A1 (en) Branched chain amino acid−dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy
NO20030295D0 (no) Anvendelse av derivater av valproinsyre- og 2- valproensyreamider for behandling av manier ved bipolare lidelser
IL143594A0 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
HUP0303041A3 (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
AU2002220735A1 (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
PL352333A1 (en) Dihydrobenzodiazepines and use of same in treatment of dislipidemia
GB9912639D0 (en) Improvements in and relating to treatment of respiratory conditions
IL131666A0 (en) Novel carboxylic acid derivatives their preparation and use in treating cancer
PL356092A1 (pl) Analogi kwasu 15-hydroksyeikozatetraenowego przerywane heteroatomem oraz sposoby ich zastosowania
EP1150669A4 (en) FORMULATIONS ON L-ARGININE BASE FOR DISEASE TREATMENT AND USE THEREOF
AU8031400A (en) 15-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disorders
PL330797A1 (en) Derivatives of piperidinacetic acid and their application in treating thrombotic disorders
PL356105A1 (pl) Analogi kwasu hydroksyeikozatetraenowego oraz sposoby ich zastosowania do leczenia zespołu suchego oka
HUP0102776A3 (en) Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release
AU3996799A (en) Alpha amino acid composition and method for the treatment of skin
HUP0204180A3 (en) External composition and its use for treating of allergic skin diseases

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)